Barclays raised the firm’s price target on LifeStance (LFST) to $9 from $8 and keeps an Overweight rating on the shares. The firm remains “optimistic” that the company’s recent investments will continue to drive productivity and growth over the next few years. It sees a buying opportunity following the recent share pullback.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFST: